Author
Listed:
- Kelley R. Healey
(Public Health Research Institute, New Jersey Medical School, Rutgers Biomedical and Health Sciences)
- Yanan Zhao
(Public Health Research Institute, New Jersey Medical School, Rutgers Biomedical and Health Sciences)
- Winder B. Perez
(Public Health Research Institute, New Jersey Medical School, Rutgers Biomedical and Health Sciences)
- Shawn R. Lockhart
(Centers for Disease Control and Prevention)
- Jack D. Sobel
(Wayne State University School of Medicine)
- Dimitrios Farmakiotis
(The University of Texas MD Anderson Cancer Center
Warren Alpert Medical School of Brown University)
- Dimitrios P. Kontoyiannis
(The University of Texas MD Anderson Cancer Center)
- Dominique Sanglard
(Institute of Microbiology of the University Hospital of Lausanne)
- Saad J. Taj-Aldeen
(Hamad Medical Corporation)
- Barbara D. Alexander
(Duke University)
- Cristina Jimenez-Ortigosa
(Public Health Research Institute, New Jersey Medical School, Rutgers Biomedical and Health Sciences)
- Erika Shor
(Public Health Research Institute, New Jersey Medical School, Rutgers Biomedical and Health Sciences)
- David S. Perlin
(Public Health Research Institute, New Jersey Medical School, Rutgers Biomedical and Health Sciences)
Abstract
The fungal pathogen Candida glabrata has emerged as a major health threat since it readily acquires resistance to multiple drug classes, including triazoles and/or echinocandins. Thus far, cellular mechanisms promoting the emergence of resistance to multiple drug classes have not been described in this organism. Here we demonstrate that a mutator phenotype caused by a mismatch repair defect is prevalent in C. glabrata clinical isolates. Strains carrying alterations in mismatch repair gene MSH2 exhibit a higher propensity to breakthrough antifungal treatment in vitro and in mouse models of colonization, and are recovered at a high rate (55% of all C. glabrata recovered) from patients. This genetic mechanism promotes the acquisition of resistance to multiple antifungals, at least partially explaining the elevated rates of triazole and multi-drug resistance associated with C. glabrata. We anticipate that identifying MSH2 defects in infecting strains may influence the management of patients on antifungal drug therapy.
Suggested Citation
Kelley R. Healey & Yanan Zhao & Winder B. Perez & Shawn R. Lockhart & Jack D. Sobel & Dimitrios Farmakiotis & Dimitrios P. Kontoyiannis & Dominique Sanglard & Saad J. Taj-Aldeen & Barbara D. Alexander, 2016.
"Prevalent mutator genotype identified in fungal pathogen Candida glabrata promotes multi-drug resistance,"
Nature Communications, Nature, vol. 7(1), pages 1-10, September.
Handle:
RePEc:nat:natcom:v:7:y:2016:i:1:d:10.1038_ncomms11128
DOI: 10.1038/ncomms11128
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:7:y:2016:i:1:d:10.1038_ncomms11128. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.